leadf
logo-loader
NASDAQ:KTRA

Kintara Therapeutics

Receive alerts
Market:
NASDAQ
Market Cap:
$36.99 m
Price
1.50 USD
Change
7.91%
52 weeks high
1.92
52 weeks low
1.03

In brief

Kintara Therapeutics is dedicated to the development of novel cancer therapies for patients with unmet medical needs.

Kintara Therapeutics has teamed up with outstanding academic and clinical research institutions from around the world to support the development of our novel cancer therapies.

Snapshot

The company has two Phase 3-ready drug development candidates and is well capitalized to achieve clinical milestones